News Quantified

ARKAY – arkema s/adr (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Filing of Arkema’s 2024 Universal Registration Document

Arkema Signs a New Biomethane Supply Agreement With ENGIE [Yahoo! Finance]

Arkema Signs a New Biomethane Supply Agreement With ENGIE

Arkema: Disclosure of Trading in Own Shares from 17 March to 21 March 2025

Former Squad Rep Cori Bush's Husband Charged With Covid Relief Fraud [zero hedge]

Top News Gainers

2/25 Arkema Is Committed to Keeping Global Warming Well Below 2°C 6.1%

4/2 Arkema is preparing the future with the ambition of becoming a Specialty Materials leader 4.6%

9/27 Arkema Completes the Acquisition of Its Partner’s Stake in Sunke 4.1%

10/15 Arkema: Disclosure of Trading in Own Shares from 07 October to 11 October 2019 3.8%

5/16 Golden Gate to exit ArrMaz in $570 mln sale [Reuters] 3.5%

8/1 Arkema Q2 EBITDA Drops To ??407 Million Euros [Reuters] 3.2%

4/6 Arkema: Disclosure of Trading in Own Shares from 30 March to 03 April 2020 2.9%

9/9 Arkema: Disclosure of trading in own shares from 02 September to 06 September 2019 2.8%

7/16 Arkema: Disclosure of Trading in Own Shares From 08 July to 12 July 2019 2.3%

7/9 ARKEMA/S (OTCMKTS: ARKAY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $99.00 price target on the stock. 1.9%

Top News Decliners

4/15 Arkema Expresses Its Solidarity Commitment in Response to the Covid-19 Crisis -8.0%

5/23 Arkema: Disclosure of Trading in Own Shares from 13 May to 17 May 2019 -5.5%

5/7 Arkema: First-quarter 2019 results -4.8%

5/12 Arkema SA (ARKAF) CEO Thierry Le Hénaff on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -4.5%

2/28 Arkema S.A. (ARKAF) CEO Thierry Le Hénaff on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.8%

7/30 Arkema Expands Sartomer’s Product Offering With the Acquisition of Lambson -3.5%

5/6 Arkema Chooses Singapore for the Production of Its Rilsan® High-Performance Bio-Sourced Polyamides -3.1%

9/20 ARKEMA/S (OTCMKTS: ARKAY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.0%

3/4 ARKEMA/S (OTCMKTS: ARKAY) was upgraded by analysts at Goldman Sachs Group Inc from a "sell" rating to a "buy" rating. -3.0%

10/8 Arkema expands its Orgasol® specialty polyamide powders capacity in France -2.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day